Steris PLC (STE)
206.00
+5.10
(+2.54%)
USD |
NYSE |
Apr 23, 16:00
206.20
+0.20
(+0.10%)
After-Hours: 19:40
Steris Research and Development Expense (Quarterly): 25.91M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 25.91M |
| September 30, 2023 | 27.04M |
| June 30, 2023 | 25.50M |
| March 31, 2023 | 26.39M |
| December 31, 2022 | 25.51M |
| September 30, 2022 | 24.93M |
| June 30, 2022 | 24.75M |
| March 31, 2022 | 26.10M |
| December 31, 2021 | 24.82M |
| September 30, 2021 | 18.83M |
| June 30, 2021 | 18.19M |
| March 31, 2021 | 17.51M |
| December 31, 2020 | 16.44M |
| September 30, 2020 | 16.14M |
| June 30, 2020 | 16.23M |
| March 31, 2020 | 17.22M |
| December 31, 2019 | 16.49M |
| September 30, 2019 | 16.25M |
| June 30, 2019 | 15.58M |
| March 31, 2019 | 15.88M |
| December 31, 2018 | 15.17M |
| September 30, 2018 | 15.77M |
| June 30, 2018 | 16.22M |
| March 31, 2018 | 17.61M |
| December 31, 2017 | 15.20M |
| Date | Value |
|---|---|
| September 30, 2017 | 13.97M |
| June 30, 2017 | 14.00M |
| March 31, 2017 | 15.76M |
| December 31, 2016 | 14.59M |
| September 30, 2016 | 14.62M |
| June 30, 2016 | 14.43M |
| March 31, 2016 | 14.31M |
| December 31, 2015 | 14.33M |
| September 30, 2015 | 14.26M |
| June 30, 2015 | 13.76M |
| March 31, 2015 | 14.18M |
| December 31, 2014 | 14.55M |
| September 30, 2014 | 13.01M |
| June 30, 2014 | 12.41M |
| March 31, 2014 | 11.68M |
| December 31, 2013 | 11.58M |
| September 30, 2013 | 13.53M |
| June 30, 2013 | 11.85M |
| March 31, 2013 | 11.73M |
| December 31, 2012 | 10.42M |
| September 30, 2012 | 9.852M |
| June 30, 2012 | 9.312M |
| March 31, 2012 | 9.086M |
| December 31, 2011 | 9.196M |
| September 30, 2011 | 8.915M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
15.58M
Minimum
Jun 2019
27.04M
Maximum
Sep 2023
21.05M
Average
18.83M
Median
Sep 2021
Research and Development Expense (Quarterly) Benchmarks
| Edwards Lifesciences Corp | 270.00M |
| Stryker Corp | 350.00M |
| Align Technology Inc | 82.16M |
| ThermoGenesis Holdings Inc | 0.329M |
| Nutriband Inc | 0.5515M |